These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33635651)

  • 1. Natural Product Based Antibody Drug Conjugates: Clinical Status as of November 9, 2020.
    Newman DJ
    J Nat Prod; 2021 Mar; 84(3):917-931. PubMed ID: 33635651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current Status of Marine-Derived Compounds as Warheads in Anti-Tumor Drug Candidates.
    Newman DJ; Cragg GM
    Mar Drugs; 2017 Mar; 15(4):. PubMed ID: 28353637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural products as a source of cytotoxic warheads in antibody-drug conjugates.
    Goel B; Jain SK
    Nat Prod Res; 2023; 37(17):2973-2985. PubMed ID: 36305758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Drug-Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody-Maytansinoid Conjugates.
    Sun X; Ponte JF; Yoder NC; Laleau R; Coccia J; Lanieri L; Qiu Q; Wu R; Hong E; Bogalhas M; Wang L; Dong L; Setiady Y; Maloney EK; Ab O; Zhang X; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2017 May; 28(5):1371-1381. PubMed ID: 28388844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical and clinical pharmacokinetic/pharmacodynamic considerations for antibody-drug conjugates.
    Sapra P; Betts A; Boni J
    Expert Rev Clin Pharmacol; 2013 Sep; 6(5):541-55. PubMed ID: 23978126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural product and natural product derived drugs in clinical trials.
    Butler MS; Robertson AA; Cooper MA
    Nat Prod Rep; 2014 Nov; 31(11):1612-61. PubMed ID: 25204227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Natural Product-Based Hybrids as Anti-Cancer Agents.
    Sflakidou E; Leonidis G; Foroglou E; Siokatas C; Sarli V
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo evaluation of cysteine and site specific conjugated herceptin antibody-drug conjugates.
    Jackson D; Atkinson J; Guevara CI; Zhang C; Kery V; Moon SJ; Virata C; Yang P; Lowe C; Pinkstaff J; Cho H; Knudsen N; Manibusan A; Tian F; Sun Y; Lu Y; Sellers A; Jia XC; Joseph I; Anand B; Morrison K; Pereira DS; Stover D
    PLoS One; 2014; 9(1):e83865. PubMed ID: 24454709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Current impact of natural products in the discovery of anticancer drugs].
    Monneret C
    Ann Pharm Fr; 2010 Jul; 68(4):218-32. PubMed ID: 20637355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody-drug conjugates for cancer.
    Chau CH; Steeg PS; Figg WD
    Lancet; 2019 Aug; 394(10200):793-804. PubMed ID: 31478503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.
    Newman DJ; Cragg GM
    J Nat Prod; 2020 Mar; 83(3):770-803. PubMed ID: 32162523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-Drug Conjugates: Functional Principles and Applications in Oncology and Beyond.
    Theocharopoulos C; Lialios PP; Samarkos M; Gogas H; Ziogas DC
    Vaccines (Basel); 2021 Sep; 9(10):. PubMed ID: 34696218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency.
    Beerli RR; Hell T; Merkel AS; Grawunder U
    PLoS One; 2015; 10(7):e0131177. PubMed ID: 26132162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enthusiasm for antibody-drug conjugates.
    Tuma RS
    J Natl Cancer Inst; 2011 Oct; 103(20):1493-4. PubMed ID: 21972230
    [No Abstract]   [Full Text] [Related]  

  • 15. The "Utility" of Highly Toxic Marine-Sourced Compounds.
    Newman DJ
    Mar Drugs; 2019 May; 17(6):. PubMed ID: 31159276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of PNU-159682 antibody drug conjugates (ADCs).
    Holte D; Lyssikatos JP; Valdiosera AM; Swinney Z; Sisodiya V; Sandoval J; Lee C; Aujay MA; Tchelepi RB; Hamdy OM; Gu C; Lin B; Sarvaiya H; Pysz MA; Laysang A; Williams S; Jun Lee D; Holda MK; Purcell JW; Gavrilyuk J
    Bioorg Med Chem Lett; 2020 Dec; 30(24):127640. PubMed ID: 33127540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computationally designed antibody-drug conjugates self-assembled via affinity ligands.
    Gupta N; Ansari A; Dhoke GV; Chilamari M; Sivaccumar J; Kumari S; Chatterjee S; Goyal R; Dutta PK; Samarla M; Mukherjee M; Sarkar A; Mandal SK; Rai V; Biswas G; Sengupta A; Roy S; Roy M; Sengupta S
    Nat Biomed Eng; 2019 Nov; 3(11):917-929. PubMed ID: 31686001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical Pharmacokinetic Considerations for the Development of Antibody Drug Conjugates.
    Kamath AV; Iyer S
    Pharm Res; 2015 Nov; 32(11):3470-9. PubMed ID: 25446773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Biological Evaluation of Shishijimicin A-Type Linker-Drugs and Antibody-Drug Conjugates.
    Nicolaou KC; Li R; Chen Q; Lu Z; Pitsinos EN; Schammel A; Lin B; Gu C; Sarvaiya H; Tchelepi R; Valdiosera A; Clubb J; Barbour N; Sisodiya V; Sandoval J; Lee C; Aujay M; Gavrilyuk J
    J Am Chem Soc; 2020 Jul; 142(29):12890-12899. PubMed ID: 32662641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical generation of small molecule-based bispecific antibody-drug conjugates for broadening the target scope.
    Yamaguchi A; Anami Y; Ha SYY; Roeder TJ; Xiong W; Lee J; Ueno NT; Zhang N; An Z; Tsuchikama K
    Bioorg Med Chem; 2021 Feb; 32():116013. PubMed ID: 33482584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.